| 書目名稱 | Mid-size Drugs Based on Peptides and Peptidomimetics |
| 副標題 | A New Drug Category |
| 編輯 | Hirokazu Tamamura,Takuya Kobayakawa,Nami Ohashi |
| 視頻video | http://file.papertrans.cn/634/633623/633623.mp4 |
| 概述 | Explains cutting-edge technical terms and new vocabulary clearly.Provides sequentially ordered descriptions ranging from basic concepts to various applications.Includes easy-to-understand figures that |
| 叢書名稱 | SpringerBriefs in Pharmaceutical Science & Drug Development |
| 圖書封面 |  |
| 描述 | This brief describes studies conducted by the authors on mid-size drugs utilizing peptides and peptidomimetics, and on the development of anti-HIV agents. Peptides are important biological molecules and have various physiological actions. Peptide-based drug discovery may help bring about the development of useful medicines that are highly safe and show potent pharmacological effects in small doses. Recently, it has been shown that there is an important drug-like space in the mid-sized region between low- and high-molecular-weight compounds. Thus, mid-size drugs such as peptide compounds are being focused on. To date, several peptidomimetics that mimic primary, secondary, and tertiary structures of peptides have been developed to maintain and improve biological activities and actions of peptides. In this book, the features and advantages of mid-size drugs are described in detail. In addition, the merits of utilizing peptidomimetics in the development of mid-size drugs are referred to. Understanding such peptide-derived mid-size drugs will lead to a comprehensive expansion of medicinal chemistry. |
| 出版日期 | Book 2018 |
| 關鍵詞 | Mid-size drug; Cyclic peptide; Peptidomimetic; Administration route; Anti-HIV agent |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-981-10-7691-6 |
| isbn_softcover | 978-981-10-7690-9 |
| isbn_ebook | 978-981-10-7691-6Series ISSN 1864-8118 Series E-ISSN 1864-8126 |
| issn_series | 1864-8118 |
| copyright | The Author(s) 2018 |
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-7 13:28
發(fā)表于 2025-3-21 19:54:31
